Showing results (311-320 of 325) with videos related to

Sort By:
Pageof 33
ERJ Open Research|October 12, 2020
Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosisYaniv Dotan, William B Shapiro, Eneida Male, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 3, 2016
The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation RecipientsY Furuya, S N Jayarajan, S Taghavi, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitorsA J Cocuzza, D R Chidester, B C Cordova, et al.
Environmental Toxicology and Chemistry|August 2, 2023
Application of Ion Mobility Spectrometry-Mass Spectrometry for Compositional Characterization and Fingerprinting of a Library of Diverse Crude Oil SamplesAlexandra C Cordova, James N Dodds, Han-Hsuan D Tsai, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitorsM Patel, R F Kaltenbach, D A Nugiel, et al.
Arthritis Research & Therapy|July 3, 2019
Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndromeC Barbati, L Stefanini, T Colasanti, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 11, 2020
COVID-19 in lung transplant recipientsCatherine N Myers, John Harwood Scott, Gerard J Criner, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Synthesis, antiviral activity and pharmacokinetics of P1/P1' substituted 3-aminoindazole cyclic urea HIV protease inhibitorsRobert F Kaltenbach, Mona Patel, Robert E Waltermire, et al.
Journal of Medicinal Chemistry|May 23, 2000
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S S Ko, J D Rodgers, et al.
Surgery in Practice and Science|July 28, 2023
Current use of the National Surgical Quality Improvement Program surgical risk calculator in academic surgery: a mixed-methods studySamuel M Miller, Sara Abou Azar, James S Farrelly, et al.
Pageof 33